RU2005140518A - Композиции и способы, включающие соединения гастрина - Google Patents

Композиции и способы, включающие соединения гастрина Download PDF

Info

Publication number
RU2005140518A
RU2005140518A RU2005140518/15A RU2005140518A RU2005140518A RU 2005140518 A RU2005140518 A RU 2005140518A RU 2005140518/15 A RU2005140518/15 A RU 2005140518/15A RU 2005140518 A RU2005140518 A RU 2005140518A RU 2005140518 A RU2005140518 A RU 2005140518A
Authority
RU
Russia
Prior art keywords
gastrin
weeks
subject
compound
composition according
Prior art date
Application number
RU2005140518/15A
Other languages
English (en)
Russian (ru)
Inventor
Антонио КРУЗ (CA)
Антонио КРУЗ
Original Assignee
Уэйрейта Фармасьютиклз, Инк. (Ca)
Уэйрейта Фармасьютиклз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/fr
Application filed by Уэйрейта Фармасьютиклз, Инк. (Ca), Уэйрейта Фармасьютиклз, Инк. filed Critical Уэйрейта Фармасьютиклз, Инк. (Ca)
Publication of RU2005140518A publication Critical patent/RU2005140518A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2005140518/15A 2003-05-27 2004-05-27 Композиции и способы, включающие соединения гастрина RU2005140518A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US03/16660 2003-05-27
PCT/US2003/016660 WO2003100024A2 (fr) 2002-05-24 2003-05-27 Traitement du diabete

Publications (1)

Publication Number Publication Date
RU2005140518A true RU2005140518A (ru) 2007-07-10

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005140518/15A RU2005140518A (ru) 2003-05-27 2004-05-27 Композиции и способы, включающие соединения гастрина

Country Status (11)

Country Link
EP (1) EP1648495A2 (fr)
JP (1) JP2007513059A (fr)
CN (1) CN1829528A (fr)
AU (1) AU2004243541A1 (fr)
BR (1) BRPI0410710A (fr)
CA (1) CA2527186A1 (fr)
MX (1) MXPA05012605A (fr)
NO (1) NO20055582L (fr)
PL (1) PL379145A1 (fr)
RU (1) RU2005140518A (fr)
WO (1) WO2004105780A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6992060B2 (en) 2001-01-12 2006-01-31 Waratah Pharmaceuticals, Inc. Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes
ATE445407T1 (de) 2002-06-07 2009-10-15 Waratah Pharmaceuticals Inc Methoden und kompositionen um diabetes zu behandeln
EP1837031B1 (fr) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Methodes et compositions pour le traitement du diabete
RU2006131046A (ru) * 2004-01-30 2008-03-10 Уэрейта Фармасьютикалз, Инк. (Ca) Совместное применение агониста glp-1 и соединений гастрина
US20100256061A1 (en) * 2007-03-02 2010-10-07 Antonio Cruz Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
EP1842552A1 (fr) * 1994-01-24 2007-10-10 The General Hospital Corporation Traitement du diabète
US6992060B2 (en) * 2001-01-12 2006-01-31 Waratah Pharmaceuticals, Inc. Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes
JP2006506386A (ja) * 2002-10-22 2006-02-23 ワラタ ファーマシューティカルズ， インコーポレイテッド 糖尿病の処置

Also Published As

Publication number Publication date
BRPI0410710A (pt) 2006-06-13
NO20055582L (no) 2006-02-27
PL379145A1 (pl) 2006-07-24
AU2004243541A1 (en) 2004-12-09
WO2004105780A2 (fr) 2004-12-09
CA2527186A1 (fr) 2004-12-09
CN1829528A (zh) 2006-09-06
EP1648495A2 (fr) 2006-04-26
WO2004105780A3 (fr) 2005-01-20
MXPA05012605A (es) 2006-02-22
JP2007513059A (ja) 2007-05-24
NO20055582D0 (no) 2005-11-25

Similar Documents

Publication Publication Date Title
ES2320754T3 (es) Tratamiento de la diabetes.
US9522175B2 (en) Method of enhancing diabetes resolution
US8202837B2 (en) Methods for administering hypoglycemic agents
Harris Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.
CA2373266A1 (fr) Utilisation d'exendines et de leurs agonistes pour le traitement du diabete sucre gestationnel
EP3689365A1 (fr) Utilisation de peptides glp-1 à action prolongée
JP2007519642A5 (fr)
SG187904A1 (en) Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
RU2019133674A (ru) Лечение сахарного диабета с помощью составов инсулинов длительного действия
US7666833B2 (en) Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
JPWO2006126673A1 (ja) 組み合わせによる糖尿病治療薬
RU2005140518A (ru) Композиции и способы, включающие соединения гастрина
WO2020130649A1 (fr) Composition pharmaceutique orale comprenant un analogue de glp-1
JP2007513059A5 (fr)
CN115947821A (zh) 一种glp-1类似物
Chakraborti Exenatide: a new promising antidiabetic agent
CA2666846C (fr) Procede pour retablir l'effet de l'incretine
US7067488B2 (en) Modified GLP-1 peptides with increased biological potency
AU2020344895A1 (en) Treatment of type 2 diabetes mellitus
CN115463208B (zh) 一种口服降糖组合物
US20090233851A1 (en) Insulin Resistance Improver
Sethi et al. INSIGHTS INTO INCRETINS IN DIABETES MANAGEMENT
JP2017081910A (ja) 血糖恒常性を維持するための医薬組成物
Potenza et al. Targeting the incretin system in type 2 diabetes mellitus
JPWO2021168386A5 (fr)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20081127